Effect of trimetazidine and verapamil on the cardiomyopathic hamster myosin phenotype

British Journal of Pharmacology

Volumn 123, Issue 4, 1998, Pages 611-616

  D'Hahan, Nathalie ^a,b,d   Taouil, Karima ^a,b   Janmot, Chantal ^c   Morel, Jean Emile ^a,b  

^a ECOLE CENTRALE PARIS   (France)

^b CEA SACLAY   (France)

^c CNRS   (France)

^d CEA GRENOBLE   (France)

Author keywords

Cardiac muscle; Cardiomyopathy; Hypertrophy; Ischaemia; Myosin ATPase activity; Myosin isozymes; Survival; Trimetazidine; Verapamil

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); CALCIUM CHANNEL BLOCKING AGENT; MYOSIN; TRIMETAZIDINE; VASODILATOR AGENT; VERAPAMIL;

ANIMAL; ARTICLE; CARDIOMYOPATHY; ENZYMOLOGY; GENETICS; HAMSTER; ISOLATION AND PURIFICATION; METABOLISM; PHENOTYPE; POLYACRYLAMIDE GEL ELECTROPHORESIS; SYRIAN HAMSTER;

ANIMALS; CALCIUM CHANNEL BLOCKERS; CALCIUM-TRANSPORTING ATPASES; CARDIOMYOPATHIES; CRICETINAE; ELECTROPHORESIS, POLYACRYLAMIDE GEL; MESOCRICETUS; MYOSINS; PHENOTYPE; TRIMETAZIDINE; VASODILATOR AGENTS; VERAPAMIL;

EID: 0031989180     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701643     Document Type: Article

References (44)

1. CHIERCHA, S.L. & FRAGASSO, G. (1993). Metabolic management of ischaemic heart disease. Eur. Heart J., 14, Suppl. G, 2 - 5.
2. CONWAY, R.S., NATELSON, B.H., CHEN, W.H. & TING, W. (1994). Enhanced coronary vasoconstriction in the Syrian myopathic hamster supports the microvascular spasm hypothesis. Cardiovasc. Res., 28, 320 - 324.
3. D'ALBIS, A. & JANMOT, C. (1993). Separation by gel electrophoresis under non-denaturing dissociating conditions (PPi-PAGE) of the native isoforms of myosin. A technical note. Basic App. Myology, 3, 235 - 238.
4. D'ALBIS, A., PANTALONI, C. & BECHET, J.-J. (1979). An electrophoretic study of native myosin isozymes and of their subunit content. Eur. J. Biochem., 99, 261 - 272.
5. D'HAHAN, N., TAOUIL, K., DASSOULI, A. & MOREL, J.E. (1997). Long term therapy with trimetazidine in cardiomyopathic Syrian hamster BIO 14:6. Eur. J. Pharmacol., 328, 163 - 174.
6. DALLA-VOLTA, S., MARAGLINO, G., DELLA-VALENTINO, P. & DESIDERI, A. (1990). Comparison of Trimetazidine with Nifedipine in effort angina: a double-blind cross-over study. Cardiovasc. Drugs Ther., 4, 853 - 860.
7. DAVIDOFF, A.J. & GWATHMEY, J.K. (1994). Pathophysiology of cardiomyopathies: part I. Animal models and humans. Curr. Opinions Cardiol., 9, 357 - 368.
8. DEMAISON, L., FANTINI, E., SENTEX, E., GRYNBERG, A. & ATHIAS, P. (1995). Trimetazidine: in vitro influence on heart mitochondrial function. Am. J. Cardiol., 76, 31B - 37B.
9. DETRY, J.M., SELLIER, P., PENNAFORTE, S., COKKINOS, D., DARGIE, H. & MATHES, P. (1994). Trimetazidine: a new concept in the treatment of angina. Comparison with propranolol in patients with stable angina. Br. J. Clin. Pharmacol., 31, 279 - 288.
10. DEVYNCK, M.A., LE QUAN SANG, K.H., JOULIN, Y. & MAZEAUD, M. (1993). Acute membrane effects of trimetazidine in human platelets. Eur. J. Pharmacol., 245, 105 - 110.
11. FACTOR, S.M., CHO, S., SCHEUER, J., SONNENBLICK, E.H. & MALHOTRA, A. (1988). Prevention of hereditary cardiomyopathy in the Syrian hamster with chronic Verapamil therapy. J. Am. Cell. Cardiol., 12, 1599 - 1604.
12. FANTINI, E., DEMAISON, L., SENTEX, E., GRYNBERG, A. & ATHIAS, P. (1994). Some biochemical aspects of the protective effect of trimetazidine on rat cardiomyocytes during hypoxia and reoxygenation. J. Mol. Cell. Cardiol., 26, 949 - 958.
13. GODFRAIND, T., KAZDA, S. & WIBO, M. (1991). Effects of a chronic treatment by nisoldipine, a calcium antagonistic dihydropyridine, on arteries of spontaneously hypertensive rats. Circ. Res., 68, 674 - 682.
14. GUARNIERI, C. & MUSCARI, C. (1993). Effect of trimetazidine on mitochondrial functions and oxidative damage during reperfusion of ischemic hypertrophied rat myocardium. Pharmacology, 46, 324 - 331.
15. HOH, J.F.Y., MCGRATH, P.A. & HALE, P.T. (1978). Electrophoretic analysis of multiple forms of rat cardiac myosin: effects of hypophysectomy and thyroxine replacement. J. Mol. Cell. Cardiol., 11, 1053 - 1076.
16. KAGIYA, T., HORI, M., IWAKURA, K., IWAI, K., WATANABE, Y., UCHIDA, S., YOSHIDA, H., KITABATAKE, A., INOUE, M. & KAMADA, T. (1991). Role of increased αl-adrenergic activity in cardiomyopathic Syrian hamster. Am. J. Physiol., 260, H80 - H88.
17. KAY, D., FINELLI, C., AUSSEDAT, J., GUARNIERI, C. & ROSSI, A. (1995). Improvement of long-term preservation of the isolated arrested rat heart by trimetazidine: effects on the energy state and mitochondrial function. Am. J. Cardiol., 76, 45B - 49B.
18. KITSIS, R. & SCHEUER, J. (1988). Correlations and dissociations between myosin isoenzymes and cardiac function. J. Appl. Cardiol., 3, 327 - 337.
19. LAMBERT, F., LECARPENTIER, Y., LOMPRE, A.-M., SCALBERT, E., DESCHE, P. & CEHMLA, D. (1995). Relations between myocardial contractility, myosin phenotype, and plasma angiotensin-converting enzyme activity in the cardiomyopathic hamster. J. Cardiovasc. Pharmacol., 25, 410 - 415.
20. LAVANCHY, N., MARTIN, J. & ROSSI, A. (1987). Anti-ischaemic effects of trimetazidine: 31P-NMR Spectroscopy in the isolated rat heart. Arch. Int. Pharmacodyn., 286, 97 - 110.
21. LOMPRE, A.M., MERCADIER, J.-J. & SCHWARTZ, K. (1991). Changes in gene expression during cardiac growth. In International Review of Cytology. Vol 124. ed. Jeon K.W., Friedlander M. pp. 137 - 186.
22. LOMPRE, A.M., MERCADIER, J.J., WISNEWSKY, C., BOUVERET, P., PANTALONI, C., D'ALBIS, A. & SCHWARTZ, K. (1981). Species-and age-dependant changes in the relative amounts of cardiac myosin isozymes in mammals. Dev. Biol., 84, 286 - 290.
23. LUBIC, S.P., GIACOMINI, K.M. &GIACOMINI, J.C. (1995). The effects of modulation of calcium influx through the voltage-sensitive calcium channel on cardiomyocyte hypertrophy. J. Mol. Cell. Cardiol., 27, 917 - 925.
24. MALHOTRA, A. (1990). Regulatory proteins in hamster cardiomyopathy. Circ. Res., 66, 1302 - 1309.
25. MALHOTRA, A., KARELL, M. & SCHEUER, J. (1985). Multiple crdiac contractile protein abnormalities in myopathic Syrian Hamsters (BIO 53:58). J. Mol. Cell. Cardiol., 17, 95 - 107.
26. MAUPOIL, V., ROCHETTE, L., TABARD, A., CLAUSER, P. & HARPEY, C. (1990). Direct measurement of free radical generation in isolated rat heart by electron paramagnetic resonance spectroscopy: effect of Trimetazidine. In Antioxydants in Therapy and Preventive Medicine. ed. Emerit, pp. 373 - 376.
27. MERCADIER, J.-J., LOMPRE, A.-M., WISNEWSK Y. C., SAMUEL, J.-L., BERCOVICCI, J., SWYNGHEDAUW, B. & SCHWARTZ, K. (1981). Myosin isoenzymic changes in several models of rat cardiac hypertrophy. Circ. Res., 49, 525 - 532.
28. MOMOMURA, S.-I., NAGAI, Y., OGAWA, T., BESSHO, M., YAMASHITA, H. & SERZAWA, T. (1993). Increased tolerance of ventricular function and energy metabolism to hypoxia in cardiomyopathic hamsters. J. Mol. Cell. Cardiol., 25, 551 - 562.
29. MOMOMURA, S.-I., YAMASHITA, H., SUGIURA, S., OHTANI, Y., SERIZAWA, T., IIZUKA, M, & SUGIMOTO, T. (1992). Cardiac adaptation and its limitation in an experimental model of congestive heart failure. Jpn. Circ. J., 56, 475 - 481.
30. NATELSON, B.H., TAPP, W.N., DRASTAL, S., SUAREZ, R. & OTTENWELLER, J.E. (1991). Hamsters with coronary vasospasm are at increased risk from stress. Psychosomatic Med., 53, 322 - 331.
31. PAULSON, D.J., GUPTA, M., ZAK, R. & ZHAO, J. (1992). Effects of exercise training and diabetes on cardiac myosin heavy chain composition. Mol. Cell. Biochem., 117, 175 - 179.
32. RAIZADA, V., PATHAK, D., NAKOUZI, A. & MALHOTRA, A. (1994). Prevention of Age-related VI myosin isozyme decrement in the adult rat heart. J. Mol. Cell. Cardiol., 26, 293 - 296.
33. 2+ regulation of trimetazidine during cardiac cell acidosis. Cardiovasc. Drugs Ther., 1, 677 - 686.
34. SAMAREL, A.M. & ENGLEMANN, G.L. (1991). Contractile activity modulates myosin heavy chain-beta expression in neonatal rat heart cells. Am. J. Physiol., 261, H1067 - H1077.
35. SCHEUER, J., MALHOTRA, A. & HIRSCH, C. (1982). Physiological cardiac hypertrophy corrects contractile protein abnormalities associated with pathologic hypertrophy in rats. J. Clin. Invest., 70, 1300 - 1305.
36. SCHWARTZ, K., MERCADIER, J.-J., SWYNGHEDAUW, B. & LOMPRE, A.-M. (1988). Modifications of gene expression in cardiac hypertrophy. Heart Failure, 4, 154 - 163.
37. SHARP, W.W., TERRACIO, L., BORG, T.K. & SAMAREL, A.M. (1993). Contractile activity modulates actin synthesis and turn-over in cultured neonatal rat heart cell. Circ. Res., 73, 172 - 183.
38. TIMOUR, Q., HARPEY, C., DURR, F. & FAUCON, G. (1991). Is the antianginal action of trimetazidine independant of hemodynamic changes? Cardiovasc, Drugs Ther., 5, 1043 - 1044.
39. VEITCH, K., MAISIN, L. & HUE, L. (1995). Trimetazidine effects on the damage to mitochondrial functions caused by ischemia and reperfusion. Am. J. Cardiol., 75, 25B - 30B.
40. VENKATAKRISHNAN, R. & ROURKE, A.W. (1979). The structure, function and turnover of cardiac myosin in normal and myopathic Syrian hamsters. Lab. Invest., 41, 198 - 205.
41. WIEGAND, V., STROH, E., HENNIGES, A., LOSSNITZER, K. & KREUZER, H. (1983). Altered distribution of myosin isoenzymes in the cardiomyopathic Syrian hamster (BIO 8.262). Basic Res. Cardiol., 78, 665 - 670.
42. WILLIAMS, F.M., TANDA, K., KUS, M. & WILLIAMS, T.J. (1992). Inhibition of neutrophile accumulation into ischaemic reperfused myocardium in the rabbit by trimetazidine. J. Mol. Cell. Cardiol., 24 (Suppl. I). S90 - S96.
43. WISENBAUGH, T., ALLEN, P. & COOPER, G. (1984). Hypertrophy without contractile dysfunction after reversal of pressure overload in the cat. Am. J. Physiol., 247, H146 - H152.
44. YAMASHITA, H., SUGIURA, S., SATA, M., SERIWAZA, T., IIZUKA, M., SHIMMEN, T. & MOMOMURA, S.-I. (1993). Depressed sliding velocity of isolated cardiac myosin from cardiomyopathic hamsters: evidence for an alteration in mechanical interaction of actomyosin. Mol. Cell. Biochem., 119, 79 - 88.